Entering text into the input field will update the search result below

VBI Vaccines GAAP EPS of $0.27 beats by $0.54, revenue of $0.63M misses by $0.17M

Mar. 07, 2022 8:13 AM ETVBI Vaccines Inc. (VBIV)By: Deepa Sarvaiya, SA News Editor6 Comments
  • VBI Vaccines press release (NASDAQ:VBIV): FY GAAP EPS of $0.27 beats by $0.54.
  • Revenue of $0.63M (-40.6% Y/Y) misses by $0.17M.
  • As of December 31, 2021 cash, cash equivalents of $121.7M compared with $119.1 million in cash, cash equivalents, and short-term investments as of December 31, 2020.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.